07.01.2025 16:29:50
|
Renovaro Inc. Appoints Nathen Fuentes As CFO
(RTTNews) - Renovaro Inc. (RENB), a leader in AI-powered cancer diagnostics and therapeutics, Tuesday, has announced the appointment of Nathen Fuentes, as Chief Financial Officer, effective January 2. He succeeds interim CFO Simon Tarsh.
Most recently, Fuentes served as CFO at Telomir Pharmaceuticals, an emerging leader in age-reversal science.
Currently RENB is trading at $1.05, up 5 percent or $0.05 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Enochian Biosciences Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Enochian Biosciences Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Enochian Biosciences Inc Registered Shs | 0,78 | -3,11% |
|